Strategic Initiative

Slingshot members are tracking this corporate initiative:

AstraZeneva (AZN) Announces License Agreement with TerSera Therapeutics for U.S and Canadian Commercial Rights to Zoladex in Prostate Cancer, Breast Cancer, and Certain Gynecological Disorders

Source Link:: https://www.sec.gov/Archives/edgar/data/901832/000165495417001208/a2531x.htm

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies

Importance

High

Medium

Low

Impact on Stocks

TerSera Therapeutics

100%

AZN

100%

SIGN ME UP
I want to vote! LOG ME IN
Now!

Slingshot Insights Explained

JOIN FOR FREE TODAY

Strategic Initiative Date

Announcement Date:

Feb 21, 2017

Projected Implementation:

Q1, 2017

Relevance Tracked Until:

Q1, 2019

Related Projects

Don’t see a project related to the strategic initiative you care about?

Related Keywords License Agreement, Zoladex, Prostate Cancer, Breast Cancer, Gynecological Disorders